John Harness
Podiatrist · Overland, MONPI 1649272493
Payments from drug & device makers
Across 349 payments — averaging $39.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$6K
- Integra Lifesciences Corporation$4K
- Koya Medical, Inc.$736
- Tactile Systems Technology Inc$662
- Smith+Nephew$654
- Organogenesis Inc.$450
- plus $2K from 28 others
What the payments were for
- Travel & lodging$3,00322%
- Food & beverage$10,39476%
- Other$2322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 45 | $5,596 |
| Integra Lifesciences Corporation | 110 | $3,726 |
| Koya Medical, Inc. | 12 | $736 |
| Tactile Systems Technology Inc | 35 | $662 |
| Smith+Nephew | 53 | $654 |
| Organogenesis Inc. | 27 | $450 |
| Stryker(2 entities) | 11 | $370 |
| Averitas Pharma Inc. | 7 | $205 |
| Nevro Corp. | 8 | $170 |
| Treace Medical Concepts, Inc. | 4 | $166 |
| Next Science LLC | 2 | $128 |
| Acera Surgical, Inc. | 3 | $125 |
| Paratek Pharmaceuticals, Inc. | 7 | $120 |
| Biowound Solutions, Inc. | 3 | $83 |
| Trice Medical, Inc. | 1 | $50 |
| Bard Peripheral Vascular, Inc. | 1 | $32 |
| Medtronic | 1 | $28 |
| ETS Wound Care LLC | 3 | $27 |
| Hydrofera LLC | 1 | $26 |
| Acell, Inc. | 1 | $25 |
| Access Pro Medical, LLC | 1 | $25 |
| Cashflow Solutions, LLC | 1 | $22 |
| Solventum Corporation | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $21 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Zimmer Biomet | 1 | $18 |
| Sanara Medtech Inc. | 1 | $18 |
| TEI Medical Inc. | 1 | $17 |
| Intuitive Surgical | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Innocoll Pharmaceuticals Limited | 1 | $16 |
| Misonix Inc | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$17,085
- Kerecis Omega3 SurgiClose$6,193
- INTEGRA$1,614
- Kerecis SurgiClose$1,275
- INTEGRA DERMAL REGENERATION TEMPLATE$1,149
- Kerecis Omega3 GraftGuide$978
- PRIMATRIX$917
- Dayspring$800
- INTEGRA WOUND MATRIX (IWM)$482
- INTEGRA MESHED BILAYER WOUND MATRIX$379
- INTEGRA FLOWABLE WOUND MATRIX$379
- Dayspring Controller$350
- LEG GARMENT, DAYSPRING, STANDARD$350
- Arm Garmet, Dayspring, Medium$350
- LOWER LEG GARMENT, DAYSPRING$350
- Kerecis GraftGuide$319
- Koya Medical$267
- Flexitouch Plus$141
- ENTRE$141
- FIXOS$120
How this compares
$13,629 in reported general payments places this provider in the 95th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 33 | $33,320 |
| Betamethasone Dipropionate | 121 | $6,114 |
| Clotrimazole | 340 | $4,925 |
| Celecoxib | 138 | $2,201 |
| Ciclopirox | 43 | $1,239 |
| Pregabalin | 49 | $896 |
| Doxycycline Hyclate | 111 | $850 |
| Ammonium Lactate | 55 | $819 |
| Diclofenac Sodium | 11 | $619 |
| Terbinafine Hcl | 47 | $488 |
| Gabapentin | 79 | $479 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $220 |
| Metronidazole | 25 | $151 |
| Levofloxacin | 41 | $149 |
| Ciprofloxacin Hcl | 11 | $109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $654 | $33,32033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 105 podiatrist providers in Missouri.
Other podiatrist in Overland
- William DukeJefferson City$148K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Ellen ColganWarrenton$10K
- Michael MarlingKansas City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.